• SENSEX
    NIFTY 50
Healthcare

US secures 300 million doses of potential AstraZeneca COVID-19 vaccine

Updated : May 22, 2020 07:33 AM IST

The US deal allows a late-stage, or Phase III, clinical trial of the vaccine with 30,000 people in the United States.
AstraZeneca has already agreed to deliver 100 million doses to people in Britain, with 30 million as soon as September.
US secures 300 million doses of potential AstraZeneca COVID-19 vaccine

You May Also Like

Live TV

recommended for you

Advertisement